A Platform and Multisided Market for Translational, Software-Defined Medical Procedures in the Operating Room (OP 4.1): Proof-of-Concept Study

Magdalena Görtz   ¹ , MD, Dr med ;   Michael Byczkowski   ² , Dipl-Math ;   Mathias Rath   ¹ , MD ;   Viktoria Schütz   ¹ , MD, Dr med ;   Philipp Reimold   ¹ , MD, Dr med ;   Claudia Gasch   ¹ , MD, Dr med ;   Tobias Simpfendörfer   ¹ , MD, Dr med ;   Keno März   ³ , PhD ;   Alexander Seitel   ³ , PhD ;   Marco Nolden   ³ , PhD ;   Tobias Ross   ³ ;   Diana Mindroc-Filimon   ³ ;   Dominik Michael   ³ ;   Jasmin Metzger   ³ ;   Sinan Onogur   ³ ;   Stefanie Speidel   ⁴ , Prof Dr ;   Lars Mündermann   ⁵ ;   Johannes Fallert   ⁵ , PhD ;   Michael Müller   ⁶ , PhD ;   Magnus von Knebel Doeberitz   ⁷ , Prof Dr ;   Dogu Teber   ⁸ , Prof Dr ;   Peter Seitz   ⁹ ;   Lena Maier-Hein   ³ , Prof Dr ;   Stefan Duensing   ¹⁰ , Prof Dr ;   Markus Hohenfellner   ¹ , Prof Dr

¹ Department of Urology, Heidelberg University Hospital, Heidelberg, Germany

² SAP SE, Walldorf, Germany

³ German Cancer Research Center, Heidelberg, Germany

⁴ National Center for Tumor Diseases, Dresden, Germany

⁵ KARL STORZ SE & Co. KG, Tuttlingen, Germany

⁶ mbits imaging GmbH, Heidelberg, Germany

⁷ Department of Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany

⁸ Department of Urology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany

⁹ Siemens Healthineers AG, Forchheim, Germany

¹⁰ Section of Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Heidelberg, Germany